ISCHEMIC STROKE / PREVENTION
Patent foramen ovale (PFO)
Created 25/01/2023, last revision 21/04/2023
- before birth, the atrial septum is formed by two leaves. After birth, the pressure rises in the left atrium and the two leaves fuse together
- in 1/3 of people, the leaves do not fuse, and a different-sized opening called a patent foramen ovale (PFO) or foramen ovale apertum (FOA) persist
- PFO causes a right-to-left shunt – blood can flow from the right atrium directly into the left atrium, bypassing the pulmonary circulation
- various particles in the blood can bypass the pulmonary circulation together with the blood and enter the systemic circulation (paradoxical embolism)
- small blood clots released from the veins of the lower limbs and pelvis
- gas bubbles (formed during rapid decompression in scuba divers or administered by IV injections)
- certain hormones (serotonin in migraine with aura?)
- PFO alone does not cause hemodynamic problems
- PFO is not the only cause of right-to-left shunting:
- intracardiac shunts (90%) – patent foramen ovale (PFO), atrial septal defects
- extracardiac shunts (10%) – mostly pulmonary AV shunts
- combination of extra- and intracardiac shunts is possible
PFO and cryptogenic stroke
- patent foramen ovale (PFO) is associated with cryptogenic stroke (CS), though the pathogenicity of discovered PFO in the setting of CS is typically unclear
- the prevalence of PFO is approx. 25% in the general population and up to 46% in patients with CS
- PFO is occasionally associated with the following conditions:
- PFO-related stroke mechanisms:
- paradoxical embolization from peripheral veins
- embolization of a thrombus formed directly within the PFO canal
Content available only for logged-in subscribers (registration will be available soon) |
Diagnostic evaluation
PFO detection
Contrast-enhanced transesophageal echocardiography (cTEE)
TCD/TCCD bubble test
- non-invasive screening method → see here
- detects all right-to-left shunts (cardiac and extracardiac)
- sensitivity and specificity reported over 90%
Other methods
D-dimers
- normal levels: 0.068-0.494 mg/L
- level <0.5 mg/L makes DVT unlikely but not impossible
- false-positive results are common
Management
- primary prevention: PFO closure not indicated
- secondary prevention: consider antiplatelet or anticoagulant therapy and PFO closure
Content available only for logged-in subscribers (registration will be available soon) |
PFO and migraine
- a higher prevalence of PFO has been reported in patients with migraine with aura than in patients with migraine without aura or patients without migraine (48% vs. 23% and 20%, respectively).
- the causal association remains unclear
- some small non-randomized trials have reported a reduced incidence of migraine after PFO closure
- randomized trials MIST (Starfix, 2016) and PREMIUM (Amplatzer, 2017) did not show a preventive effect
- in conclusion, it is less likely that PFO plays a role in the development migraine headache
- the role of PFO in the development of ischemic stroke in migraineurs has not been determined yet
- patients with both migraine and stroke had larger shunts than patients with migraine without stroke, patients without migraine with stroke, and controls
- with respect to the white matter hyperintensities (WMH), overall WMH did not differ by PFO presence; however, juxtacortical WMH are more frequently found in patients with migraine and right-to-left shunting
- these findings suggest that incidental PFO may increase the risk of ischemic stroke in migraineurs